• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[大肠功能紊乱的诊断与治疗新成果]

[New results in the diagnosis and therapy of functional disorders of the large intestine].

作者信息

Frolkis A W

出版信息

Dtsch Z Verdau Stoffwechselkr. 1986;46(2):122-9.

PMID:3720635
Abstract

The most important pathophysiological mechanism of functional disorders of colon is motility disturbance. The best term for these disturbances is considered to be "colon dyskinesia". Dyskinesia can be classified as primary and secondary, and as hyperand hypokinetic. The following clinical forms are distinguished: with constipation, painless diarrhea, isolated pain syndrome, colica mucosa. Inflammatory diseases of colon are accompanied by chemical changes in feaces: the increase of enterokinase and alkalien phosphatase activity (enzymorrhea), the increase of feacal excretion of protein (proteinorrhea). Both enzymorrhea and proteinorrhea are absent in colon dyskinesia. The investigation of enzymes and protein in faeces can be of great help in differential diagnostics of functional and inflammatory colon diseases. In treating colon dyskinesia psychopharmacological, cholinolytical, spasmolytical and antidiarrrheal preparations are used, as well as some drugs with purgative effect. Clinical and instrumental methods make it possible to determine which type of the motility disturbances predominates. The latter is important for differential prescription of drugs correcting colon motility in colon dyskinesia. Colon motility in man ist actively affected by adrenergic drugs: it is inhibited by adrenomimetics and stimulated by adrenolytics which justifies their prescription in colon dyskinesia. Diazepam and phenobarbital inhibit colon motility. Diphenoxylate and metoclopramide have a normalizing effect.

摘要

结肠功能紊乱最重要的病理生理机制是运动障碍。这些障碍的最佳术语被认为是“结肠运动障碍”。运动障碍可分为原发性和继发性,以及运动亢进和运动减退。可区分出以下临床形式:伴有便秘、无痛性腹泻、孤立性疼痛综合征、黏膜绞痛。结肠炎症性疾病伴有粪便中的化学变化:肠激酶和碱性磷酸酶活性增加(酶泻),粪便蛋白质排泄增加(蛋白泻)。结肠运动障碍时既无酶泻也无蛋白泻。粪便中酶和蛋白质的检测对功能性和炎症性结肠疾病的鉴别诊断有很大帮助。在治疗结肠运动障碍时,使用精神药理学、抗胆碱能、解痉和止泻制剂,以及一些具有泻药作用的药物。临床和器械检查方法能够确定哪种类型的运动障碍占主导。后者对于在结肠运动障碍中纠正结肠运动的药物的鉴别性处方很重要。人体内的结肠运动受到肾上腺素能药物的积极影响:肾上腺素能激动剂会抑制它,而肾上腺素能阻滞剂会刺激它,这证明了它们在结肠运动障碍中的处方合理性。地西泮和苯巴比妥会抑制结肠运动。地芬诺酯和甲氧氯普胺具有调节作用。

相似文献

1
[New results in the diagnosis and therapy of functional disorders of the large intestine].[大肠功能紊乱的诊断与治疗新成果]
Dtsch Z Verdau Stoffwechselkr. 1986;46(2):122-9.
2
[Irritable colon--a stable diagnosis?].[过敏性结肠——一种可靠的诊断?]
Schweiz Med Wochenschr. 1971 May 22;101(20):759-60.
3
[Motility disturbances of the large intestine].[大肠的运动障碍]
Z Gesamte Inn Med. 1981 Jan 1;36(1):suppl 194-6.
4
[Diagnostic significance of enzymorrhea].[酶性腹泻的诊断意义]
Klin Med (Mosk). 1984 May;62(5):27-31.
5
[The irritable colon].
Schweiz Med Wochenschr. 1982 Feb 27;112(9):314-9.
6
[Effect of tiropramide chlorhydrate on intestinal transit time in patients with irritable colon syndrome].[盐酸替罗普胺对肠易激综合征患者肠道转运时间的影响]
Minerva Med. 1985 May 12;76(19-20):923-6.
7
[Drug therapy of gastrointestinal motility disorders].[胃肠动力障碍的药物治疗]
Fortschr Med. 1980 Aug 21;98(30-31):1144-6.
8
[Dietary and drug therapy of intestinal disease].
Med Klin. 1980 Jun 6;75(12):429-35.
9
[The biogenic amine level of patients with functional and inflammatory diseases of the large intestine].[大肠功能和炎症性疾病患者的生物胺水平]
Vrach Delo. 1990 Dec(12):66-9.
10
[Clinical manifestations, diagnosis and treatment of dyskinesia of the large intestine and chronic nonulcerative colitis].[大肠运动障碍与慢性非溃疡性结肠炎的临床表现、诊断及治疗]
Klin Med (Mosk). 1983 Apr;61(4):43-8.